Story · Medicine & Biotech
STAT+: Despite Novo drug’s failure, cardiologists say they will still pursue anti-inflammatories
1 outlet · first reported by STAT News 4d ago
Coverage, in order
-
4d ago
STAT+: Despite Novo drug’s failure, cardiologists say they will still pursue anti-inflammatoriesCHICAGO — Out-of-control inflammation is often called the root of all evil in cardiovascular and metabolic disease. Recent clinical trial results, described in brief in July , showed that while an experimental drug could lower two biomarkers of inflammation, it didn’t limit serious heart events in…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.